BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng H, Zhang M, Ma S, Yang W, Xie S, Wang Y, Liu Y, Kai J, Ma Q, Lu R, Guo L. Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients. Cancer Med 2020;9:5200-9. [PMID: 32441484 DOI: 10.1002/cam4.3122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Drumond-Bock AL, Bieniasz M. The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis. Mol Cancer 2021;20:145. [PMID: 34758842 DOI: 10.1186/s12943-021-01424-5] [Reference Citation Analysis]
2 Mathilakathu A, Borchert S, Wessolly M, Mairinger E, Beckert H, Steinborn J, Hager T, Christoph DC, Kollmeier J, Wohlschlaeger J, Mairinger T, Schmid KW, Walter RFH, Brcic L, Mairinger FD. Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective study. Transl Lung Cancer Res 2021;10:3030-42. [PMID: 34430345 DOI: 10.21037/tlcr-21-201] [Reference Citation Analysis]
3 Xu H, Li X, Wang S, Li F, Gao J, Yan L, Zhu L. Multiomics analysis identifies key genes and pathways related to N6-methyladenosine RNA modification in ovarian cancer. Epigenomics 2021;13:1359-83. [PMID: 34550011 DOI: 10.2217/epi-2021-0204] [Reference Citation Analysis]
4 Zheng H, Zhang M, Ma S, Yang W, Xie S, Wang Y, Liu Y, Kai J, Ma Q, Lu R, Guo L. Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients. Cancer Med 2020;9:5200-9. [PMID: 32441484 DOI: 10.1002/cam4.3122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]